We are live on ! Find out more
MSAC

Medicus Sciences Acquisition Corp. Class A Ordinary Share

Delisted

MSAC was delisted on the 17th of February, 2023.

54 hedge funds and large institutions have $99.4M invested in Medicus Sciences Acquisition Corp. Class A Ordinary Share in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 9

4% less capital invested

Capital invested by funds: $103M → $99.4M (-$3.68M)

2% less funds holding

Funds holding: 5554 (-1)

17% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 6

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

Holders
54
Holders Change
-1
Holders Change %
-1.82%
% of All Funds
0.85%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
5
Increased
11
Reduced
9
Closed
6
Calls
$13K
Puts
Net Calls
+$13K
Net Calls Change
-$25K
Name Holding Trade Value Shares
Change
Change in
Stake
CFIA
26
Cantor Fitzgerald Investment Advisors
New York
$965K
SIA
27
Schechter Investment Advisors
Michigan
$958K +$18.1K +1,860 +2%
CCA
28
Cruiser Capital Advisors
Connecticut
$904K
BCM
29
Beryl Capital Management
California
$803K -$70.1K -7,202 -8%
AC
30
Ayrton Capital
Connecticut
$730K
RCM
31
Rivernorth Capital Management
Florida
$489K
HighTower Advisors
32
HighTower Advisors
Illinois
$397K
Millennium Management
33
Millennium Management
New York
$395K -$32.9K -3,379 -8%
SSA
34
Schonfeld Strategic Advisors
New York
$389K -$2.3K -236 -0.6%
HF
35
HRT Financial
New York
$345K +$4.86K +499 +1%
RCM
36
Robinson Capital Management
Michigan
$294K
Bank of Montreal
37
Bank of Montreal
Ontario, Canada
$246K
Verition Fund Management
38
Verition Fund Management
Connecticut
$245K
LC
39
Littlejohn & Co
Connecticut
$196K
Goldman Sachs
40
Goldman Sachs
New York
$178K +$11.7K +1,200 +7%
Susquehanna International Group
41
Susquehanna International Group
Pennsylvania
$176K +$62.5K +6,423 +56%
GCIA
42
Gabelli & Co Investment Advisers
New York
$151K
GF
43
Gabelli Funds
New York
$143K
E
44
Ergoteles
New York
$133K
CCM
45
Condor Capital Management
New Jersey
$127K +$99.5K +10,230 +371%
RCM
46
Radcliffe Capital Management
Pennsylvania
$116K
MIG
47
Mariner Investment Group
New York
$98K
ICMH
48
Integrity Capital Management (HK)
Hong Kong
$97K +$96.3K +9,894 New
Ohio Public Employees Retirement System (OPERS)
49
Ohio Public Employees Retirement System (OPERS)
Ohio
$38K +$37.9K +3,900 New
TRCT
50
Tower Research Capital (TRC)
New York
$17K +$5.96K +613 +55%

MSAC Hedge Fund Activity: Q1 2022 in Review

54 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) for Q1 2022, worth a combined $99.4M — down 3.6% from $103M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of MSAC and 5 opened new positions — a net loss of 1 holder — while 9 trimmed existing stakes and 11 added.

The largest buyer was Cowen and Company, opening a new position worth an estimated $4.86M. The largest seller was Third Point, exiting entirely with an estimated $7.68M sold.

  • 54 institutional investors held Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) as of Q1 2022, down from 55 in Q4 2021.
  • Funds reported $99.4M of Medicus Sciences Acquisition Corp. Class A Ordinary Share stock for Q1 2022, down 3.6% quarter-over-quarter.
  • 5 funds opened new Medicus Sciences Acquisition Corp. Class A Ordinary Share positions in Q1 2022 and 6 closed out, a net change of -1 holder.
  • The largest Medicus Sciences Acquisition Corp. Class A Ordinary Share buyer in Q1 2022 was Cowen and Company, an estimated $4.86M added.
  • The largest Medicus Sciences Acquisition Corp. Class A Ordinary Share seller in Q1 2022 was Third Point, an estimated $7.68M sold.

Based on aggregated 13F filings for Q1 2022.